BMJ Open Diabetes Research & Care

Scope & Guideline

Empowering the diabetes community with open access knowledge.

Introduction

Welcome to your portal for understanding BMJ Open Diabetes Research & Care, featuring guidelines for its aims and scope. Our guidelines cover trending and emerging topics, identifying the forefront of research. Additionally, we track declining topics, offering insights into areas experiencing reduced scholarly attention. Key highlights include highly cited topics and recently published papers, curated within these guidelines to assist you in navigating influential academic dialogues.
LanguageEnglish
ISSN-
PublisherBMJ PUBLISHING GROUP
Support Open AccessNo
Country-
Type-
Converge-
AbbreviationBMJ OPEN DIAB RES CA / BMJ Open Diab. Res. Care
Frequency6 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressBRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND

Aims and Scopes

BMJ Open Diabetes Research & Care focuses on advancing the understanding, prevention, and management of diabetes and its complications through high-quality research. The journal emphasizes interdisciplinary approaches and aims to bridge the gap between clinical practice and research.
  1. Diabetes Epidemiology and Public Health:
    The journal publishes studies examining the epidemiology of diabetes, including prevalence, incidence, and risk factors across different populations, with a focus on public health implications and interventions.
  2. Clinical Management and Treatment Strategies:
    Research on various treatment modalities, including pharmacological and non-pharmacological interventions for diabetes management, is a core focus. This includes studies on the efficacy and safety of new diabetes medications and technologies.
  3. Complications of Diabetes:
    BMJ Open Diabetes Research & Care explores the various complications associated with diabetes, such as cardiovascular disease, nephropathy, retinopathy, and neuropathy, and their impact on patient outcomes.
  4. Health Disparities and Social Determinants of Health:
    The journal emphasizes research addressing health disparities in diabetes care and outcomes, focusing on socioeconomic, ethnic, and geographic factors that influence diabetes management and health equity.
  5. Innovative Research Methodologies:
    The use of advanced research methodologies, including machine learning, big data analytics, and system dynamics modeling, to improve diabetes care and outcomes is highlighted.
  6. Patient-Centered Research:
    Studies focusing on patient-reported outcomes, self-management, and the psychosocial aspects of living with diabetes are significant, aiming to enhance patient engagement and quality of care.
Recent publications in BMJ Open Diabetes Research & Care reflect emerging trends and themes that are gaining traction in diabetes research. These areas highlight the evolving landscape of diabetes care, incorporating new technologies, interdisciplinary approaches, and a greater emphasis on health equity.
  1. Digital Health and Telemedicine:
    The integration of digital health technologies, including telemedicine and remote monitoring tools, into diabetes care is increasingly prominent, especially in the context of the COVID-19 pandemic's impact on healthcare delivery.
  2. Precision Medicine and Personalization:
    Research focusing on precision medicine approaches tailored to individual patient profiles, including genetic, metabolic, and lifestyle factors, is on the rise, reflecting a shift towards more personalized diabetes management.
  3. Diabetes and Mental Health:
    There is growing recognition of the interplay between diabetes and mental health, with studies exploring the psychological aspects of living with diabetes, including stress, depression, and the impact on glycemic control.
  4. Environmental and Socioeconomic Influences:
    Research examining the impact of environmental factors and socioeconomic status on diabetes prevalence, management, and outcomes is increasingly relevant, highlighting the importance of social determinants of health.
  5. Machine Learning and Data Analytics:
    The application of machine learning and data analytics in diabetes research is emerging as a key trend, offering insights into risk prediction, disease progression, and treatment optimization.

Declining or Waning

While BMJ Open Diabetes Research & Care continues to cover a wide range of diabetes-related topics, certain areas of research have seen a decrease in publication frequency or relevance. These waning themes may indicate shifting priorities within the field or a saturation of research in those areas.
  1. Traditional Dietary Interventions:
    Research focusing solely on traditional dietary interventions for diabetes management has declined, as newer studies explore more complex interactions involving microbiota, metabolic pathways, and personalized nutrition.
  2. Basic Science and Preclinical Studies:
    There has been a noticeable reduction in the publication of basic science and preclinical studies, with a shift towards more applied clinical research and real-world evidence that directly informs diabetes care.
  3. Single-Factor Studies:
    Research examining the effects of single factors (e.g., one specific medication or lifestyle change) on diabetes outcomes has decreased, as there is a growing emphasis on multifactorial approaches and comprehensive care models.

Similar Journals

Journal of Endocrinology Metabolism and Diabetes of South Africa

Fostering discourse on critical health challenges.
Publisher: ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTDISSN: 1608-9677Frequency: 3 issues/year

Journal of Endocrinology Metabolism and Diabetes of South Africa, published by Routledge Journals, Taylor & Francis Ltd, serves as a vital platform for advancing research and knowledge dissemination in the fields of endocrinology, metabolism, and diabetes. Since its transition to Open Access in 2012, it has enabled greater accessibility to crucial findings and data, broadening its reach to researchers, practitioners, and students alike. Though its coverage in Scopus was discontinued in 2018, the journal continues to play an important role in fostering discourse in the medical community, as evidenced by its ranking within the 19th and 16th percentiles for Internal Medicine and Endocrinology, diabetes and metabolism, respectively. With its commitment to addressing pressing health issues in South Africa and beyond, this journal remains an invaluable resource for those seeking to understand and tackle the complexities of metabolic diseases.

DIABETES-METABOLISM RESEARCH AND REVIEWS

Exploring Innovations in Diabetes Management
Publisher: WILEYISSN: 1520-7552Frequency: 8 issues/year

DIABETES-METABOLISM RESEARCH AND REVIEWS, published by WILEY, is an esteemed academic journal focusing on the forefront of research in the fields of endocrinology, diabetes, and metabolism. Since its inception in 1999, this journal has become a crucial resource for researchers, professionals, and students, boasting an impressive impact factor that reflects its high citation rates and contribution to the field. With a 2023 classification of Q1 in several categories including Endocrinology and Internal Medicine, it ranks among the top journals globally, demonstrating its significant influence and authority. The journal serves as a platform for the dissemination of innovative research, reviews, and methodologies that advance understanding and treatment of metabolic disorders. By offering valuable insights and fostering collaboration within the scientific community, DIABETES-METABOLISM RESEARCH AND REVIEWS is essential reading for anyone involved in diabetes research and clinical practice.

Science of Diabetes Self-Management and Care

Elevating Standards in Diabetes Research and Practice
Publisher: SAGE PUBLICATIONS INCISSN: 2635-0106Frequency: 6 issues/year

Science of Diabetes Self-Management and Care is an esteemed journal published by SAGE Publications Inc, dedicated to advancing research and knowledge in the fields of endocrinology, diabetes management, and health professions. Established in 2021, this peer-reviewed, open-access journal aims to provide a platform for the dissemination of innovative and practical strategies for diabetes self-management and care, meeting the needs of an increasingly diverse patient population. With an impressive impact factor reflective of its quality and relevance, the journal has achieved notable rankings—Q2 in Endocrinology, Diabetes and Metabolism, and Q1 in Health Professions and Social Sciences, underscoring its significance in both clinical practice and healthcare research. Researchers, healthcare professionals, and students will find valuable insights and breakthroughs in diabetes care, making this journal an essential resource for those seeking to contribute to the future of diabetes self-management."

ACTA DIABETOLOGICA

Pioneering Research in Endocrinology and Diabetes
Publisher: SPRINGER-VERLAG ITALIA SRLISSN: 0940-5429Frequency: 12 issues/year

ACTA DIABETOLOGICA, published by SPRINGER-VERLAG ITALIA SRL, is a distinguished peer-reviewed journal dedicated to the rapidly evolving fields of endocrinology, diabetes, and metabolism. With an impressive convergence of research from 1991 to 2024, it is recognized for its significant contributions, boasting a Q1 ranking in Internal Medicine and Q2 rankings in Endocrinology categories as of 2023. Its Scopus rankings further highlight its impact, placing it in the 81st percentile in Internal Medicine. The journal serves as a vital platform for professionals and researchers, facilitating the dissemination of innovative findings and fostering a comprehensive understanding of metabolic disorders. Although the journal is not open access, it remains an essential resource, ensuring high visibility and accessibility of critical research to its scholarly audience.

Diabetes Epidemiology and Management

Advancing Insights for a Healthier Tomorrow
Publisher: ELSEVIERISSN: Frequency: 4 issues/year

Diabetes Epidemiology and Management, published by Elsevier, is an innovative open-access journal that has been addressing the critical issues surrounding diabetes since its inception in 2021. This journal integrates a comprehensive exploration of the epidemiology, prevention, and management of diabetes, making it a pivotal resource within the fields of Endocrinology, Diabetes and Metabolism, and Internal Medicine. With a digital presence represented by E-ISSN 2666-9706, it currently holds a commendable position in the academic landscape, categorized in the Q3 quartile for both Endocrinology and Internal Medicine as per the 2023 metrics. The journal aims to enhance understanding and promote research on diabetes, offering authors a platform to share their findings with a global audience. Researchers, professionals, and students alike can benefit from this essential resource, which is dedicated to advancing the knowledge base and improving clinical practices in diabetes management. With open access options since 2021, the journal ensures that vital research is widely accessible, driving innovation and collaboration in the fight against diabetes.

International Journal of Cardiology Cardiovascular Risk and Prevention

Exploring New Frontiers in Cardiovascular Medicine
Publisher: ELSEVIERISSN: 2772-4875Frequency: 4 issues/year

International Journal of Cardiology Cardiovascular Risk and Prevention is a distinguished Open Access journal published by ELSEVIER, dedicated to advancing research in the realms of cardiology and cardiovascular medicine. With an ISSN of 2772-4875 and based in the Netherlands, this journal has rapidly established itself as a critical resource for academics and practitioners since its inception in 2021. The journal currently holds a respectable impact factor and occupies the Q2 quartile in both Cardiology and Cardiovascular Medicine and Internal Medicine categories, reflecting its commitment to sharing high-quality research. Researchers can take advantage of its open-access model, ensuring that cutting-edge findings are freely available to a global audience. The journal not only covers innovative studies on cardiovascular risk factors and prevention strategies but also aims to facilitate interdisciplinary collaboration. With an ongoing trajectory from 2021 to 2024, the International Journal of Cardiology Cardiovascular Risk and Prevention is poised to remain a pivotal platform for dialogue and discovery in the evolving landscape of cardiovascular health.

British Journal of Diabetes

Pioneering studies for a healthier future in diabetes care.
Publisher: ASSOC BRITISH CLINICAL DIABETOLOGISTSISSN: 2397-6233Frequency: 2 issues/year

The British Journal of Diabetes, published by the Association of British Clinical Diabetologists, is a premier journal dedicated to advancing the understanding, prevention, and management of diabetes. With an ISSN of 2397-6233, this journal aims to disseminate high-quality research findings, clinical studies, and reviews that address the complexities of diabetes care and research. While currently not available as an open access option, the journal is committed to enhancing the visibility of cutting-edge diabetes research for healthcare professionals and academics. Located in the heart of England, this journal plays a crucial role in bridging the gap between clinical practice and research innovation, making it an essential resource for practitioners, researchers, and students alike. The British Journal of Diabetes is determined to contribute significantly to the global dialogue on diabetes, as it covers a wide spectrum of topics from epidemiology and public health to novel therapeutic strategies and patient management approaches.

DIABETOLOGIA

Unveiling the latest in diabetes research and clinical practice.
Publisher: SPRINGERISSN: 0012-186XFrequency: 12 issues/year

DIABETOLOGIA is a leading journal in the field of endocrinology and diabetes research, published by Springer since its inception in 1965. With an impactful presence in both Internal Medicine and Endocrinology, Diabetes and Metabolism, it is recognized in the Q1 quartile rankings for 2023, underscoring its significance and contribution to these disciplines. The journal holds impressive Scopus rankings, placing it in the top 5% of journals in its categories, making it an essential resource for researchers, healthcare professionals, and students dedicated to advancing knowledge and practices in diabetes care and management. DIABETOLOGIA publishes a range of peer-reviewed articles, original research, and reviews that address the latest scientific developments, clinical practices, and therapeutic innovations, contributing to the global discourse on diabetes and its related health implications. Although it does not offer Open Access options, its rigorous selection process guarantees the quality and relevance of the content, solidifying its position as a reliable reference for contemporary research. For those looking to stay at the forefront of diabetes science, DIABETOLOGIA is a vital communique in the ever-evolving landscape of medical research.

International Journal of Diabetes in Developing Countries

Exploring solutions for diabetes challenges in resource-limited settings.
Publisher: SPRINGER INDIAISSN: 0973-3930Frequency: 4 issues/year

The International Journal of Diabetes in Developing Countries, published by SPRINGER INDIA, stands as a pivotal resource in the field of diabetes research, particularly focusing on the challenges and advancements in diabetes management within developing nations. With an ISSN of 0973-3930 and an E-ISSN of 1998-3832, this journal has been fostering knowledge exchange since its inception in 2001, converging its focus over multiple years to maintain relevance through 2024. As a peer-reviewed journal, it holds a significant position within the Q4 category of Endocrinology, Diabetes and Metabolism and Q3 in Internal Medicine, showcasing its commitment to addressing critical issues regarding diabetes care in diverse populations. The journal is crucial for researchers, healthcare professionals, and students seeking to further their understanding of diabetes in resource-limited settings. Although it operates without an open access model, the journal ensures rigorous peer review, maintaining high academic standards that benefit the growing field of diabetes research. With its address located in the heart of New Delhi, India, this publication serves as a vital repository for valuable insights and innovative strategies aimed at combating diabetes in developing countries.

Diabetologie

Elevating endocrinology through rigorous scholarship.
Publisher: SPRINGER HEIDELBERGISSN: 2731-7447Frequency: 8 issues/year

Diabetologie is a dedicated academic journal published by Springer Heidelberg, focusing on the diverse fields of endocrinology, diabetes, and metabolism. With the ISSN 2731-7447 and E-ISSN 2731-7455, this journal serves as a significant platform for the dissemination of innovative research and evidence-based practices within the rapidly evolving landscape of diabetes care and management. Although currently not classified as Open Access, the journal provides robust subscription options that grant access to a wealth of peer-reviewed articles, making it an invaluable resource for researchers and practitioners alike. With an H-index that reflects its emerging influence and a Scopus ranking in the 10th percentile within its category, Diabetologie aims to elevate the scientific understanding of diabetes through rigorous scholarship. The journal captures the latest findings and clinical advancements from 2022 to 2024, placing a particular emphasis on novel therapeutic strategies and technological innovations. By fostering a collaborative environment dedicated to the improvement of diabetes outcomes, Diabetologie stands as a crucial contributor to the global dialogue on diabetes treatment and research.